Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Hemo

<< Previous

Bullboard Posts

Next >>

Post by BioTeckon Jun 30, 2021 12:40pm

198 Views

Post# 33473630

Hemo

This is something we "worked" on. Not working on. Pay attention to his choice of words. They are very telling.

Now with the bought deal they will be moving this fwd. 6 months later. Also, just lip service. How exactly are they going to move it forward? What is the plan?

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs